Mental Health Antidepressants and Mood Stabilizers

Cards (55)

  • Benign Prostatic Hyperplasia (BPH)
    Glandular units in the prostate gland undergo tissue hyperplasia, resulting in an enlarged prostate
  • Treatments for BPH
    • Alpha-adrenergic antagonists
    • 5-Alpha-reductase inhibitors
    • Anticholinergics
    • Phosphodiesterase-5 inhibitors
  • The client with BPH should avoid drugs that can cause urinary retention such as anticholinergics, antihistamines, and decongestants
  • Alpha-adrenergic antagonists

    • Side effects: CNS - dizziness, headache; CV - orthostatic hypotension; Other - decreased libido, URI, priapism
  • Patient teaching for alpha-adrenergic antagonists
    They are also used to control BP, advise using at bedtime, take with food
    1. Alpha-reductase inhibitors
    Drug names: Finasteride & Dutasteride
    1. Alpha-reductase inhibitors

    • Side effects: Endo - decreased libido, erectile dysfunction, gynecomastia; CV - orthostatic hypotension
  • Patient teaching for 5-Alpha-reductase inhibitors
    Safety: women of childbearing age must not handle crushed or broken tablets, wear gloves when handling tablets
  • Anticholinergics
    Side effects: SLUDGE
  • Phosphodiesterase-5 inhibitors

    • Most commonly used medical treatment for ED, facilitate erection by enhancing blood flow to the penis
  • Phosphodiesterase-5 inhibitors side effects
    • Headache (most common), dyspepsia, nasal congestion & nasopharyngitis; Rare side effects: blurred vision, photosensitivity, sensitivity to light and blue-green color tint, hearing loss, tinnitus, seizures, priapism, and urinary tract symptoms such as dysuria and cloudy or bloody urine
  • Patient teaching for Phosphodiesterase-5 inhibitors
    Do not drink grapefruit juice, nitroglycerin/other nitrate medications used to treat heart disease can cause a significant decrease in blood pressure when taken with PDE-5 inhibitors, obtain list of drugs taken by patient, wear sunscreen/protection
  • First Generation Antipsychotics (Conventional)
    • Strong blockade of dopamine in the CNS causing serious movement disorders (EPS), has 2 action unlike the 2nd gen
  • Second Generation Antipsychotics (Atypical)

    • Moderate blockage of dopamine in the CNS, much stronger blockage of receptors for serotonin, the risk of EPS is lower than with the first-generation antipsychotics, carry a significant risk of metabolic effects such as weight gain, diabetes, and dyslipidemia
  • Fluphenazine (Phenothiazine subgroup)

    Blocks dopamine receptors in brain and controls psychotic symptoms
  • Fluphenazine side effects
    • CNS: sedation, dizziness, headache, blurred vision, seizures, cerebral edema, EPS;
    • Cardiac: orthostatic hypotension, dysrhythmias;
    • Other: sexual dysfunction, urinary retention, dry mouth
  • Haloperidol (Butyrophenone class)

    Alters the effect of dopamine on the CNS, the mechanism for antipsychotic effects is unknown
  • Haloperidol uses and contraindications
    • Treats psychoses, schizophrenia, attention-deficit/hyperactivity disorder, Tourette's syndrome;
  • Haloperidol side effects
    • CNS: EPS (acute dystonia, akathisia, tardive dyskinesia), parkinsonism, sedation;
    • CV: prolonged QT interval, orthostatic hypotension;
    • Weight gain, sexual dysfunction
  • Clozapine (Second-Generation Antipsychotics)
    First atypical agent used to treat schizophrenia and other psychoses
  • Clozapine side effects
    • CNS: sedation, tremors, blurred vision; GI: dry mouth, constipation; CV: tachycardia, orthostatic hypotension; Low possibility of EPS
  • Clozapine adverse effects
    • Seizures, agranulocytosis - Need to monitor WBC count for leukopenia
  • Anxiolytics - Benzodiazepines withdrawal

    Gradually decrease dose over several days, symptoms develop slowly in 2 to 10 days and may last several weeks
  • Benzodiazepine withdrawal symptoms
    • Short term use: CNS - tremor, agitation, nervousness, sweating, insomnia; GI - anorexia; Long term use: paranoia, delirium, panic, hypertension, status epilepticus
  • Tricyclic Antidepressants (TCA's)

    Side effects: CV - orthostatic hypotension; CNS - sedation, seizures; Other - sexual dysfunction, suicidal ideation; Anticholinergic effects - tachycardia, urinary retention, constipation, dry mouth, blurred vision
  • TCA's adverse reactions
    Cardiotoxicity - serious effects are rare in the absence of overdose or pre-existing cardiac impairment; Overdose is life threatening - related to anticholinergic and cholinergic blockade
  • TCA's patient teaching
    Administration - start low and increase; Onset of therapeutic response is delayed regardless of dosage; Once daily dosing at bedtime; Caution in elderly; Gradually decreased to avoid withdrawal symptoms
  • Selective Serotonin Reuptake Inhibitors (SSRIs)

    More commonly used to treat depression than TCAs due to fewer side effects; Do not cause hypotension, sedation, anticholinergic effects, or cardiotoxicity as do many of the TCAs
  • SSRI side effects
    • CNS - headache, blurred vision, insomnia, nervousness; GI - dry mouth, nausea, vomiting, diarrhea, anorexia; Other - sexual dysfunction
  • SSRI withdrawal syndrome

    Dizziness, headache, nausea, sensory disturbances, tremor, anxiety and dysphoria
  • SSRI patient teaching
    Taper the dose slowly, grapefruit juice with SSRIs can lead to toxicity, side effects often decrease over 1 to 4 weeks
  • Monoamine Oxidase Inhibitors (MAOIs)

    Used if Depression is not controlled by TCAs and second-generation antidepressants; Effective as TCAs but due to serious adverse reactions very few patients take MAOIs as an antidepressant
  • MAOI side effects

    • CNS side effects,
    • CV - orthostatic hypotension
    • Anticholinergic effects,
    • Hypertensive crisis from tyramine interactionliver toxicity
  • MAOI patient teaching
    Frequent blood pressure monitoring, some drug interactions can be fatal, avoid CNS stimulants and certain foods that can cause a hypertensive crisis
  • Lithium
    Therapeutic range: 0.8 to 1.2 mEq/L; Alteration of ion transport in muscle and nerve cells, increased receptor sensitivity to serotonin
  • Lithium uses
    • Bipolar disorder (1st drug used), manic episodes
  • Lithium side effects
    • CNS SE
    • GI - metallic taste, thirst, dry mouth
    • Renal - polyuria, dehydration
    • CV - hypotension, peripheral edema
    • Other - weight gain/loss
  • Lithium adverse effects

    • Urinary and fecal incontinence, hyperglycemia, proteinuria, leukocytosis, nephrotoxicity;
  • Lithium patient education
    Cannot be taken during pregnancy,
    increased sodium intake
    increases renal excretion,
    increased urine output can result in body fluid loss and dehydration,
    adequate fluid intake of 1 to 2 liters
  • Lithium nursing interventions
    Observe client for depression, mood changes, insomnia, apathy, or lack of interest in activities; Monitor vital signs, lithium levels, cardiac status; Advise client to avoid caffeine products, monitor sodium intake and fluid intake; Monitor for toxicity; Mouth checks to see if patient swallowed it